Dr. Burak GümüşçüAesthetic & Health Technologies
Hair Health

4 min read

Exosome Hair Therapy Sessions: What Sets the Number

Exosome hair therapy sessions: how many are needed, what sets the number and why not upfront? A short, plain guide to the subject for anyone deciding.

Asking about exosome hair therapy sessions and getting a number before examination means no personal plan is being built. This treatment is planned as a series and its length is set by the picture. This article covers how the plan is built.

Why a series?

Short answer: Because what is targeted is support for the scalp, and that does not form from a single treatment. A gradual process is at work.

The hair cycle is slow too; reading a change by eye takes months.

So the series gets discussed as a whole plan rather than as a sum of individual sessions.

What sets the number?

The type and duration of the loss is the first factor.

The second is the underlying cause; where there is a medical cause it is addressed first.

The third is the technique used. Micro-injection and application alongside microneedling do not call for the same plan.

Why is the first result waited for?

Short answer: Because the response cannot be known in advance. The first treatments are also a measurement round and the plan is built on that measurement.

The interval or the treated area can be updated according to the response.

The scalp is reassessed before every session.

How is the interval set?

The interval is not arbitrary; it is set by the hair cycle and by the tissue settling.

Shortening it does not speed the process up; a treatment given early is given without seeing how much work the previous one did.

A longer interval is generally not a problem; after a pause the treatment is assessed from where it stands.

What happens when the series ends?

The assessment is made once the series is complete, and that can fall months later.

Where the intended change has been achieved the maintenance interval is discussed; how long results last is covered separately.

Where the response is below expectation the picture is reassessed rather than sessions added.

Why can the number not be found online?

Session numbers shared are selected examples and reflect those people's pictures.

This field is relatively new too; the FDA consumer alert notes that this product group is unapproved, which makes relying on individual accounts more misleading still.

Being able to verify the product is licensed matters for the same reason; what exosome hair therapy is is covered separately.

How long is the whole process?

Short answer: The intervals set the duration as much as the number of sessions. The whole process can spread over months and that is discussed at the outset.

That is a detail affecting planning, particularly for people travelling from outside the city.

When results show is covered separately. The treatment's own page sits under exosome hair therapy.

Frequently asked questions

Would one session be enough? It would not. What is targeted is support for the scalp and that does not form from a single application; the hair cycle is slow too. That is why the treatment is planned as a series and the assessment is made once the series is complete rather than partway through.

If I miss a session, do we start over? No. There is no accumulating course between treatments; after a pause the treatment is assessed from where it stands. How the loss behaved during the gap is valuable information for the next decision and goes into the plan. Pausing is not counted as a loss.

Are sessions added if I see no result? Not automatically. Where the response is markedly below expectation the picture is reassessed first. If an underlying medical cause was missed, raising the number of sessions does not cross that limit and the process only lengthens unnecessarily.


If you would like to talk through the source of your hair loss and what series would suit it, the consultation assesses the scalp by examination.

This article is for general information and is not medical advice. Assessment and treatment decisions follow a medical examination; results vary between individuals.

References

  1. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — FDA
  2. Hair loss — NHS
  3. Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK)